Late last week, UVA announced it will launch a biotechnology institute, the Paul and Diane Manning Institute of Biotechnology, with a $100 million donation from Charlottesville investor Paul Manning and his wife, Diane. UVA will also contribute $150 million, and the state of Virginia has allocated $50 million in initial investments for the institute in its 2022-24 budget.
Forecyte Bio, a leading China-based CDMO biotech company, recently celebrated the grand opening of its new facility in Frederick County, Maryland. The 17,000 square foot location is dedicated to contract development and manufacturing for the rapidly growing Cell and Gene Therapy industry. The facility aims to provide a “one-stop” holistic service package to help accelerate clients’ projects from early concept to commercial manufacturing.
Sirnaomics Ltd. (Stock Code: 2257 HK) and its affiliates and subsidiaries (collectively, “Sirnaomics”), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, celebrated Sirnaomics’ 15th anniversary of RNAi therapeutic innovation globally, along with the grand opening of the new headquarters and laboratories for its US subsidiary in Germantown, Maryland, on Dec. 15, 2022.
JLL’s Capital Markets group announced today that it has arranged a $290 million construction loan that will allow project partners Gattuso Development Partners and Vigilant Holdings of New York to build a state-of-the-art research facility at 3201 Cuthbert Street, an 11-story life sciences development in the heart of Philadelphia’s University City submarket.
The new lab space will allow the company to progress its pipeline with minimal delay and expenditure. The CIC Philadelphia-based lab space, which has undergone a recent expansion to double the number of available benches, will serve as one of Verismo’s in-house translational research and process development work. The work conducted at the site will support the ongoing activities for the SynKIR-110 clinical trial and future pipeline products including SynKIR-210 and SynKIR-310.
A new, purpose-built facility at 2500 League Island Boulevard in the heart of Philadelphia will bring much-needed world-class manufacturing and R&D space to a burgeoning life sciences ecosystem. The large building, 130,000 ft2 with 30 ft clear height, will accommodate the unique demands of life sciences manufacturing, as will its large floor slabs and abundant roof-top utilities.
Haystack Oncology and Longeviti Neuro Solutions, life science companies affiliated with Johns Hopkins University, have signed leases at City Garage Science and Technology Center totaling over 30,000 square feet in Baltimore Peninsula. Additionally, Launchport has expanded their operations by 6,200-sf.
On November 3, public officials and FITCI partners gathered at the nonprofit’s portion of the building at 321 Ballenger Creek to celebrate the new beginning. The ceremony concluded with elected officials and partners kicking off the renovations themselves by taking down a wall with golden sledgehammers.
As the U.S. commercial real estate market adapts to rising interest rates and a less certain outlook for the economy, the life sciences sector remains a strong performer. But some signs of a slowdown are appearing even here.
In the third quarter, occupancy dipped to 94 percent across the top 12 U.S. life sciences markets—from a peak of 95 percent in the first quarter of 2022, according to a November report from commercial real estate services firm CBRE. CBRE also registered a 30-basis-point increase in quarter-over-quarter vacancy, to 5.3 percent. That was largely due to a significant amount of new supply (2.1 million sq. ft.) hitting the market, leading the addition of available new space to outpace absorption of 363,047 sq. ft., the firm’s researchers estimate.
Capital Digestive Care is delighted to announce that our new, 22,000 square foot, state-of-the-art laboratory has been recognized as a Roche Diagnostics Center of Excellence, the first GI specialty practice in the United States with the designation.